3 August, 2018
The North Carolina BioSciences Organization (NCBIO) recently welcomed ARANZ Medical as one of their newest members.
NCBIO provides their partner organizations with industry information and policy news, helps connect them with legislators at local, state and federal levels, and provides a channel to voice policy issues affecting the industry.
ARANZ Medical’s Head of Clinical Research Business Development – North America, Tim LaCroix says, “NCBIO is a vital organization not only for early stage development companies but also for established Biotech companies needing strategic input and access to valuable resources. As a member of this fine organization, it will bring ARANZ Medical’s innovative Silhouette skin and wound imaging to regional and national biotech companies that need to collect this essential clinical trial data.”
NCBIO is dedicated to promoting the future growth and development of the region’s bioscience industry. Their ultimate goal is to help North Carolina’s bioscience community be a source of economic opportunity and deliver an improved quality of life for their citizens and others around the world.
